Has the NHS joined the biosimilars revolution?Biosimilars have cut the price of biologic drugs by up to 80% on the NHS, according to Paul Share XHas the NHS joined the biosimilars revolution?https://pharmaphorum.com/oncology/nhs-joined-biosimilar-revolution/
How the NHS got ahead of the curve with CAR-TThe UK’s pharma industry has welcomed the NHS’ fast adoption of the latest CAR-T cancer therapies. Richard Staines Share XHow the NHS got ahead of the curve with CAR-Thttps://pharmaphorum.com/views-analysis-oncology/nhs-got-ahead-curve-car-t/
Merck KGaA’s bold new approach to cancer immunotherapyGermany’s Merck KGaA is hoping to stand out from the crowd with a bold new approach to cancer Share XMerck KGaA’s bold new approach to cancer immunotherapyhttps://pharmaphorum.com/views-analysis-oncology/merck-kgaas-bold-new-approach-to-cancer-immunotherapy/
Quality of life increasingly important in skin cancer, say doctors at this year’s ESMOThe factors a doctor should consider when choosing between therapies that could cure patients with skin cancer proved Share XQuality of life increasingly important in skin cancer, say doctors at this year’s ESMOhttps://pharmaphorum.com/views-analysis-oncology/quality-of-life-increasingly-important-in-skin-cancer-esmo/
Ahead of the curvePharma often criticises the NHS for failing to adopt the latest therapies, arguing that NICE’s technology appraisals can Share XAhead of the curvehttps://pharmaphorum.com/views-analysis-oncology/ahead-curve-car-t/
Digital health technology has the potential to transform cancer careDigital and connected health technology has real potential to transform cancer care, writes Piotr Wnuk. Start-ups are utilising Share XDigital health technology has the potential to transform cancer carehttps://pharmaphorum.com/views-analysis-oncology/digital-health-technology-has-potential-to-transform-cancer-care/
Communication problems holding back new cancer treatments Cancer immunotherapy is revolutionising oncology – but the Havas Lynx Group’s chief medical officer Vernon Bainton argues that the incredible progress is Share XCommunication problems holding back new cancer treatments https://pharmaphorum.com/oncology/communication-problems-holding-back-new-cancer-treatments/
The power of blockchain in cancer care transformationOver the course of the last decade blockchain technology has slowly filtered through from the underground to the Share XThe power of blockchain in cancer care transformationhttps://pharmaphorum.com/views-and-analysis/blockchain-power-cancer-care/
Oncolytics: the dawn of a new era in cancer treatmentOncolytic virus therapy is not a new discovery, but it may now be positioned as the next major Share XOncolytics: the dawn of a new era in cancer treatmenthttps://pharmaphorum.com/views-analysis-oncology/oncolytics-new-era-cancer-treatment/
